Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
52 participants
INTERVENTIONAL
2019-10-31
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For the patient, knowing the limits of his visual field and learning to adapt is necessary especially when traveling.
The management of these patients is twofold:
* an orthoptist carries out an overall evaluation of the visual field using the Goldmann device (30 cm projection of the areas seen and not seen by the patient's eye), then performs rehabilitation over several weeks
* an instructor of locomotion (open specialization: occupational therapist, case of this project,...) carries out an evaluation in situation, followed by a personalized reeducation over several weeks. The first sessions consist in establishing a climate of confidence, presenting the objectives of the management of locomotion and begin to understand the movements inside and outside accompanied. The following of the rehabilitation is an apprenticeship of the optimal use of the residual field of vision and the proposed technical aids (white cane), in the whole of the displacements, inside and outside.
The residual field of vision is evaluated by a device at the first appointment at the specialized center. This examination, necessary for the professional, is not informative for the patient. It is sometimes supplemented by the evaluation of the visual field of view (ECVS). The ECVS, done jointly by the orthoptist and the locomotion instructor, consists in evaluating the functional visual field on a horizontal plane at 1m (meter) and 5m, and vertical at 5m. The field of vision of the patient, immobile, is materialized by targets deposited at each limit of the zones seen that it indicates.
The investigators believe that the passing of a visual field on the ground, thanks to the projection of the zones of vision, allows the patient to improve his knowledge on his visual possibilities (and gaps) and thus to make his reeducation more efficient.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life Activities
NCT04448860
Optical Head-Mounted Display Technology for Low Vision Rehabilitation
NCT02983305
Evaluation of Objective Perimetry Using Pupillometer
NCT01021982
Perception of Objects and Natural Scenes in People With Vision Loss (ACTIVIS)
NCT02862405
Mobility Protocol Adapted for Advanced Visually Impaired Subjects
NCT04419285
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
evaluation of the visual field on the ground
evaluation of the visual field on the ground followed by 10 reeducation sessions
evaluation of the visual field on the ground
evaluation of the visual field on the ground
usual care
control session followed by 10 re-education sessions
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
evaluation of the visual field on the ground
evaluation of the visual field on the ground
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with retinitis pigmentosa
* a visual field less than or equal to 20 degrees regardless of the degree of visual acuity
* lack of peripheral islets
* to be able to move without a white detection cane
* have signed an informed consent
* be an affiliate or beneficiary of a French social security system.
Exclusion Criteria
* impossibility to follow the protocol
* Limitation of locomotion activities related to other than visual impairments: neurological disorders (hemiplegia, neuropathy, ...)
* musculoskeletal disorders (arthropathies ...)
* Any participation in a protocol having an impact on the walking path by Virtual Reality
* person under the protection of justice, or under guardianship or curators
* pregnant or lactating woman
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Limoges
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I15007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.